Edition:
United Kingdom

Abeona Therapeutics Inc (ABEO.OQ)

ABEO.OQ on NASDAQ Stock Exchange Capital Market

4.43USD
24 Jun 2019
Change (% chg)

$-0.19 (-4.11%)
Prev Close
$4.62
Open
$4.73
Day's High
$4.73
Day's Low
$4.41
Volume
240,940
Avg. Vol
133,652
52-wk High
$17.25
52-wk Low
$4.41

About

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)

Overall

Beta: 2.29
Market Cap(Mil.): $713.08
Shares Outstanding(Mil.): 40.29
Dividend: --
Yield (%): --

Financials

  ABEO.OQ Industry Sector
P/E (TTM): -- 69.29 32.55
EPS (TTM): -0.60 -- --
ROI: -29.33 8.90 13.82
ROE: -30.75 10.04 15.24

Earnings vs. Estimates